NASDAQ:OCUL - Ocular Therapeutix Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$5.73 -0.10 (-1.72 %)
(As of 12/12/2018 04:00 PM ET)
Previous Close$5.83
Today's Range$5.71 - $6.00
52-Week Range$4.28 - $8.28
Volume357,600 shs
Average Volume430,204 shs
Market Capitalization$239.18 million
P/E Ratio-2.60
Dividend YieldN/A

Analyst Ratings

Ocular Therapeutix (NASDAQ:OCUL) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for Ocular Therapeutix in the last 12 months. Their average twelve-month price target is $13.60, suggesting that the stock has a possible upside of 137.35%. The high price target for OCUL is $24.00 and the low price target for OCUL is $9.00. There are currently 6 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $13.60$13.6667$13.25$13.00
Price Target Upside: 137.35% upside124.78% upside97.76% upside93.16% upside

Ocular Therapeutix (NASDAQ:OCUL) Consensus Price Target History

Price Target History for Ocular Therapeutix (NASDAQ:OCUL)

Ocular Therapeutix (NASDAQ:OCUL) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/4/2018HC WainwrightReiterated RatingBuy$12.00MediumView Rating Details
12/4/2018CowenReiterated RatingBuy$13.00MediumView Rating Details
12/3/2018Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$22.00 ➝ $24.00HighView Rating Details
11/14/2018Raymond JamesInitiated CoverageStrong-Buy ➝ Strong-Buy$10.00HighView Rating Details
10/11/2018JMP SecuritiesReiterated RatingBuy$9.00HighView Rating Details
9/6/2018Piper Jaffray CompaniesInitiated CoverageOverweight ➝ OverweightLowView Rating Details
3/11/2018BTIG ResearchReiterated RatingBuyHighView Rating Details
10/23/2017GuggenheimInitiated CoverageBuy$12.00N/AView Rating Details
7/14/2017Morgan StanleyReiterated RatingEqual Weight$16.00 ➝ $8.00LowView Rating Details
(Data available from 12/12/2016 forward)
This page was last updated on 12/12/2018 by Staff

Featured Article: Compound Interest

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel